These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8608907)

  • 41. Should omeprazole be used for the treatment and prevention of duodenal ulcer as a monotherapeutic agent?
    Kadayifci A; Oksüzöğlu G
    Am J Gastroenterol; 1996 Jun; 91(6):1279-80. PubMed ID: 8651198
    [No Abstract]   [Full Text] [Related]  

  • 42. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A; Serrano Aulló MT
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract]   [Full Text] [Related]  

  • 43. [Target for anti-ulcer agents--pH, H. pylori or NO?].
    Nielsen AM; Madsen JR
    Nord Med; 1994; 109(3):81-3. PubMed ID: 8139901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Helicobacter pylori and the gastroduodenal mucosa.
    Kokoska ER; Kauffman GL
    Surgery; 2001 Jul; 130(1):13-6. PubMed ID: 11436006
    [No Abstract]   [Full Text] [Related]  

  • 45. Helicobacter pylori, gastric acid, and duodenal gastric metaplasia.
    McColl KE
    Gut; 1996 Oct; 39(4):615-6. PubMed ID: 8944576
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of pantoprazole- vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population.
    Aladağ M; Kantarçeken B; Karincaoğlu M; Sertkaya A; Cikim K; Harputluoğlu MM; Demirel U; Alan H; Ateş F; Yildirim B; Hilmioğlu F
    Turk J Gastroenterol; 2005 Dec; 16(4):242-3. PubMed ID: 16547858
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The impact of the degree of Helicobacter pylori semination of the mucous coat of stomach in patients with duodenal ulcer on the infectious organism's eradication].
    Kas'ianenko VI
    Eksp Klin Gastroenterol; 2004; (3):19-23, 102. PubMed ID: 15560395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy.
    Lambert JR
    Gastroenterology; 1996 Aug; 111(2):521-3. PubMed ID: 8690219
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
    Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
    Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Peptic ulcer due to Helicobacter pylori].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 1998 May; 87(5):832-6. PubMed ID: 9648433
    [No Abstract]   [Full Text] [Related]  

  • 52. [Eradicating treatment against Helicobacter pylori].
    Barrera Linares F; Gomollón García F; Caballero Herráez P; Valdepérez Torrubia JJ
    Aten Primaria; 1998 Oct; 22(7):469-70, 472. PubMed ID: 9842090
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevention of hemorrhage from intradiverticular ulcer in the duodenum by Helicobacter pylori eradication.
    Sugimoto M; Kajimura M; Hanai H; Kaneko E
    Am J Gastroenterol; 2000 Feb; 95(2):561-2. PubMed ID: 10685780
    [No Abstract]   [Full Text] [Related]  

  • 54. [Selecting variants of drug treatment of non-complicated duodenal ulcer (based on a study of results of Rabeprazole efficiency)].
    Vasil'ev IuB
    Eksp Klin Gastroenterol; 2004; (3):14-8, 102. PubMed ID: 15560394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ulcerogenesis: integrating the roles of Helicobacter pylori and acid secretion in duodenal ulcer.
    Peura DA
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):8S-13S; discussion 13S-16S. PubMed ID: 9127621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Helicobacter pylori and perturbations in acid secretion: the end of the beginning.
    Graham DY
    Gastroenterology; 1996 May; 110(5):1647-50. PubMed ID: 8613075
    [No Abstract]   [Full Text] [Related]  

  • 57. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
    Iijima K; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(25):7709-17. PubMed ID: 26167071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reacquisition of Helicobacter pylori following eradication: does long-term acid suppression really matter?
    Parente F
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):34-5. PubMed ID: 9615261
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice.
    Watanabe K; Murakami K; Sato R; Kashimura K; Miura M; Ootsu S; Miyajima H; Nasu M; Okimoto T; Kodama M; Fujioka T
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4582-8. PubMed ID: 15561829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Helicobacter pylori infection and omeprazole efficacy.
    Verdú EF; Bercík P; Armstrong D; Labenz J; Blum AL
    Gastroenterology; 1996 Nov; 111(5):1401-2. PubMed ID: 8898663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.